Explore the evolving discussion on Zionism and its implications for the two-state solution in today's American Jewish ...

The removal of outdated value caps on duty-free gold jewellery will bring clarity, compliance and ease travel stress, say community and business leaders.

The most common symptoms are shortness of breath and cough, and the progression of the disease varies considerably from person to person. However, many people with IPF experience flare-ups or ...

Dec 29 (Reuters) - British lender International Personal Finance (IPF.L), opens new tab said on Monday it has agreed to a 543 million-pound ($732.51 million) takeover by a company associated with ...

International Personal Finance ( (GB:IPF)) just unveiled an announcement. International Personal Finance Plc has announced an extension to the deadline for BasePoint Capital LLC to finalize its ...

Barreling toward the end of its cash runway, GRI Bio has shared phase 2a data in idiopathic pulmonary fibrosis (IPF) and made the case for further development of its potentially disease-modifying ...

Boehringer Ingelheim has secured FDA approval for its PDE4 inhibitor nerandomilast (Jascayd) for the treatment of idiopathic pulmonary fibrosis (IPF), a chronic and fatal lung disease. Nerandomilast ...

My journey to a diagnosis of idiopathic pulmonary fibrosis (IPF) began in the fall of 2016, when I was 59. It all started with a persistent cough. While the cough was annoying, especially to my wife, ...

Sept 24 (Reuters) - Britain's International Personal Finance (IPF.L), opens new tab said on Wednesday it received an increased 514.9 million pounds ($693.31 million) takeover proposal from U.S.-based ...

Fifty-five countries competed at the 2025 International Powerlifting Federation World Championships held in San Jose, Costa Rica, on Aug. 26-Sept. 5, and once again, St. Tammany Parish was well ...

United Therapeutics is making headway in unlocking a new lung disease market for its drug Tyvaso (treprostinil) with a pivotal phase 3 win in idiopathic pulmonary fibrosis (IPF). United’s Teton-2 ...

United Therapeutics jumps 40% as Tyvaso s쳮ds in late-stage IPF trial. Tyvaso could expand into a $5.5B IPF market, diversifying revenue streams. Strong sales, cash reserves, and buybacks boost UTHR’s ...